On January 29th, 2024, the proposed combination of the legacy companies Novozymes, already a China Europe Carbon Neutral (CNEUCN) strategic partner, and Chr. Hansen was successfully completed, establishing the company Novonesis. Novonesis is a world-leading biosolutions partner for better business, healthier lives, and a healthier planet. The combined company brings together 10,000 people worldwide and an expertise that spans more than 30 different industries. Novonesis is already assisting companies around the world in meeting both business needs and the needs of the planet.
The combination of Novozymes and Chr. Hansen creates a leading global biosolutions partner with a broad biological toolbox and a diversified portfolio in attractive markets. The combined group will have annual revenue of approximately EUR 3.7 billion1 with solid profitability and cash generation.
Half of the portfolio will focus on enabling healthier lives and producing better foods. The other half will address reducing chemical use and targeting climate neutral practices. The combined group will operate a global network of R&D and application centers as well as manufacturing sites and will employ around 10,000 talented and purpose-driven employees who are inspired by the power of biosolutions.
Last year, Novozymes established a formal strategic partnership with CNEUCN and its experts joined the CNEUCN’s Experts’ Committee. The newly established Novonesis will further expand the resource network of CNEUCN, bringing advanced concepts and mature biological solutions to various decarbonization and emission reduction projects from Europe to China.
In 2023, Novozymes also participated in the theme conference “The Transition towards Carbon Neutrality” at the 17th EU-CHINA Business & Technology Cooperation Fair hosted by CNEUCN. Dr Li Hao, representative from Novozymes, put forward the corporate views on the current energy supply in China and insights for improvement, as well as the efforts Novozymes has made in decarbonization and carbon reduction.
In the new year, CNEUCN looks forward to continuing and further increasing its excellent partnership with Novonesis. We will cooperate to promote Novonesis advanced biosolutions from Europe in the Chinese market, to add bricks and mortar to China’s path towards carbon neutrality, assisting Chinese companies to transform their business and final users to upgrade their daily lives using advanced biotechnology solutions.
China Europe Carbon Neutral Technology aims to support and substantially contribute to China and Europe path towards carbon neutrality in a holistic and inclusive way by gathering all the stakeholders and creating solutions for each challenge.
China Europe Carbon Neutral Technology will play an active and innovative role in providing services to conceive, shape, design and accomplish the transitions needed to achieve carbon neutrality.